Excellent news promannkind! This is evidence supporting my suspicion that Sanofi's soft launch was to target "early adopter" endos with large practices so that the word goes "viral" so to speak. This also helps explain why Jefferies' analyst had to change his mnkd price target to $37 given Afrezza penetration at 4X his original estimate.
"Dr Anne Peters demonstrates the use of the new inhaled insulin device and reminds clinicians what to discuss with patients when initiating this new agent.
Experts And Viewpoints, Medscape Diabetes & Endocrinology, May 2015"
I'm not a member so I couldn't access the full article.
I wasn't even nasty. Feuerstein blocked me as well a while back. Two who can't handle the truth. That said, I see that Cramer now says that he has only been talking about the stock, not the drug. In so many words he has admitted Afrezza works imo. I believe this is the beginning of his slow turnaround. In due time he will be claiming he was the first to get people into the stock.
Here is what he said, "I think it is TERRIFIC if $MNKD helps people. But people are asking me about the stock, And I said it was too high"
David Kliff has yet to elaborate on the harsh business realities. I have asked him several times to tell me why he believe Afrezza will be a niche drug and the response has been nothing but crickets. He claims to be a T1 diabetic but has no interest in trying Afrezza. I don't trust him. He is friends with Feuerstein - that should tell you all you need to know.
I sold OPK in the 5's after making a couple of thousand. I never sold it in my son's account since the number of shares was so small. I have watched it climb ever since. Win some, lose some I guess. ;)
Thanks for posting. Elsewhere Feuerstein has directly referred to Kliff as his friend.
These were awarded to board members with varying conditions as per the footnotes as follows below. Number 3 is interesting - annual retainer received in stock in lieu of cash. Does anyone know if this is the annual retainer to board members has always been handled or if this is something new?
1. 3-year vesting period; 1/36th vesting every month, being fully vested 05/21/2016.
2. Annual retainer received in equity in lieu of cash. Restricted Stock Units shall vest on the earlier of retirement, removal from board, death or five years from grant date.
3. Annual retainer received in equity in lieu of cash. Restricted Stock Units shall vest on the earlier of retirement or removal from board, provided that such retirement or removal occurs more than one year after grant date; death; or five years from grant date.
If I am not mistaken, these are stock options which they have the right to buy with a conversion price of $4.63. Right now they are in the money, but there is a vesting period for these as well.
Since I have been blocked by Cramer I picked up Cramer's twt second hand from another Twtr member:
"At $5 I hope MNKD makes money for you and that it helps people. No much more to say,..." (Cramer)
I'm loving this. FP88
That's what it looks like. Strange.
These are the footnotes I copied and pasted directly from the form 4. Not sure what you're getting at. The only stock they could sell are those covered under #1, and in that case they can only sell 1/36 of the total shares, and not until they vest 1 month from the date they were granted (i.e. on June 21, 2015). Tell me where I'm wrong - I have no hidden agenda and have no problem being corrected if I'm wrong.
He is disrespectful to those who legitimately challenge his opinion (including yours truly) and much of his opinion is not backed by fact but rather by the need to aid and abet shorts in their attempts to drive the share price down. His articles appear to be coordinated with short attacks. Maybe the latter is just a coincidence, but given the number of times the two have been hand in hand, I think not.